Natalia Mas
Overview
Explore the profile of Natalia Mas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Silva Y, Sanchez-Cirera L, Terceno M, Dorado L, Valls A, Martinez M, et al.
Eur Stroke J
. 2023 May;
8(2):557-565.
PMID: 37231687
Introduction: Previous studies have reported differences in the management and outcome of women stroke patients in comparison with men. We aim to analyze sex and gender differences in the medical...
2.
Flores A, Garcia-Tornel A, Sero L, Ustrell X, Requena M, Pellise A, et al.
J Neurointerv Surg
. 2023 Apr;
16(2):143-150.
PMID: 37068936
Background: The influence of vascular imaging acquisition on workflows at local stroke centers (LSCs) not capable of performing thrombectomy in patients with a suspected large vessel occlusion (LVO) stroke remains...
3.
Garcia-Tornel A, Flores A, Terceno M, Cardona P, Amaro S, Gomis M, et al.
Stroke
. 2023 Feb;
54(3):770-780.
PMID: 36848432
Background: We aim to assess whether time of day modified the treatment effect in the RACECAT trial (Direct Transfer to an Endovascular Center Compared to Transfer to the Closest Stroke...
4.
Olive-Gadea M, Perez de la Ossa N, Jovin T, Abilleira S, Jimenez X, Cardona P, et al.
Int J Stroke
. 2022 Apr;
18(2):229-236.
PMID: 35373657
Background: Acute ischemic stroke patients not referred directly to a comprehensive stroke center (CSC) have reduced access to endovascular treatment (EVT). The RACECAT trial is a population-based cluster-randomized trial, designed...
5.
Flores A, Sero L, Gomez-Choco M, Ustrell X, Pellise A, Vinas J, et al.
J Stroke Cerebrovasc Dis
. 2021 Nov;
31(1):106209.
PMID: 34794029
Background: In drip-and-ship protocols, non-invasive vascular imaging (NIVI) at Referral Centers (RC), although recommended, is not consistently performed and its value is uncertain. We evaluated the role of NIVI at...
6.
Flores A, Ustrell X, Sero L, Pellise A, Rodriguez P, Vinas J, et al.
Cerebrovasc Dis
. 2020 Oct;
49(5):550-555.
PMID: 33091908
Background: The evolution of the symptomatic intracranial occlusion during transfers from primary stroke centers (PSCs) to comprehensive stroke centers (CSCs) for endovascular treatment (EVT) is not widely known. Our aim...
7.
Belvis R, Mas N
Recent Pat CNS Drug Discov
. 2015 Feb;
9(3):181-92.
PMID: 25643127
Chronic migraine is the most frequent and disabling complication of migraine. To date, only two drugs have been specifically analysed for the treatment of chronic migraine, topiramate and onabotulinumtoxin A,...
8.
Belvis R, Mas N, Roig C
Rev Neurol
. 2015 Jan;
60(2):81-9.
PMID: 25583591
Introduction: The International Headache Society (IHS) has published the third edition of the International Classification of Headache Disorders (ICHD-III beta), the most commonly used guide to diagnosing headaches in the...
9.
Pont-Sunyer C, Hotter A, Gaig C, Seppi K, Compta Y, Katzenschlager R, et al.
Mov Disord
. 2014 Dec;
30(2):229-37.
PMID: 25449044
Nonmotor symptoms (NMS) in Parkinson's disease (PD) can precede onset of motor symptoms. Relationship between premotor symptoms onset and motor features is limited. Our aim is to describe the presence...
10.
Belvis R, Mas N, Aceituno A
Recent Pat CNS Drug Discov
. 2014 Mar;
9(1):26-40.
PMID: 24605940
About 15% of people in the world suffer migraine attacks. Migraine can induce a great impact in the quality of life, and the costs of medical care and loss of...